u-PA expression in benign, borderline and malignant ovarian tumors

被引:0
|
作者
Kiziridou, AD
Toliou, T
Stefanou, D
Agnantis, N
机构
[1] Theagen Anticanc Inst thessaloniki, Dept Pathol, Thessaloniki 54007, Greece
[2] Univ Ioannina, Sch Med, Dept Pathol, Ioannina 45100, Greece
关键词
plasminogen activator; ovarian carcinoma; borderline tumors; immunohistochemistry;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The malignant potential of solid tumors is related to their ability to invade adjacent tissue and to metastasize. The plasminogen activation system is one of the critical factors in tumor progression since it is involved in tumor invasion and metastasis. This study was performed to examine the expression of u-PA in benign, borderline and malignant tumors of the ovary by immunohistochemical evaluation on formalin-fixed, paraffin-embedded specimens applying monoclonal antibody 3689 directed to the b-chain of u-PA. Normal epithelial cells of the ovary (n =5) showed no staining of u-PA but some stromal cells were slightly stained. Invasive carcinomas (n=16) and borderline tumors (n = 15) showed a moderate to strong diffuse cytoplasmic staining. Benign tumors (n=20) showed a variety of staining. The observation of randomly positive u-PA stromal cells is noteworthy. The percentage of u-PA-positive tumors was higher in carcinomas than in other tumors. There was no con-elation with other known risk factors of malignancy such as differentiation, stage or type of tumor, In conclusion there are noticeable differences in u-PA expression among ovarian tumors and u-PA increase in ovarian tumors can be attributed to an increased diffuse cytoplasmic content in the neoplastic epithelial cells.
引用
收藏
页码:985 / 990
页数:6
相关论文
共 50 条
  • [41] WT1 expression in ovarian borderline and malignant surface epithelial tumors
    Tahamtan, M.
    Aslani, F. Sari
    Safaee, A.
    [J]. VIRCHOWS ARCHIV, 2012, 461 : S314 - S314
  • [42] Metallothionein expression and nuclear size-in benign, borderline, and malignant serous ovarian tumours
    Tan, Y
    Sinniah, R
    Bay, BH
    Singh, G
    [J]. JOURNAL OF PATHOLOGY, 1999, 189 (01): : 60 - 65
  • [43] Genetic alterations in benign and borderline malignant breast tumors
    DalCin, P
    Christiaens, MR
    Bullerdiek, J
    VandenBerghe, H
    Moerman, P
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 : 12 - 12
  • [44] CLINICAL STUDY OF T-PA AND U-PA EXPRESSION IN PATIENTS WITH GASTROINTESTINAL CANCER
    吴方
    璩斌
    巩云霞
    王学锋
    杨晨敏
    王鸿利
    [J]. Chinese Journal of Cancer Research, 2005, (02) : 97 - 102
  • [45] Risk of borderline ovarian tumors among women with benign ovarian tumors: A cohort study
    Guleria, Sonia
    Jensen, Allan
    Kjaer, Susanne K.
    [J]. GYNECOLOGIC ONCOLOGY, 2018, 148 (01) : 86 - 90
  • [46] BRENNER TUMORS OF THE OVARY - A STUDY OF THE HISTOLOGY, IMMUNOHISTOCHEMISTRY AND CELLULAR DNA CONTENT IN BENIGN, BORDERLINE AND MALIGNANT OVARIAN-TUMORS
    TREBECK, CE
    FRIEDLANDER, ML
    RUSSELL, P
    BAIRD, PJ
    [J]. PATHOLOGY, 1987, 19 (03) : 241 - 246
  • [47] Microvessel quantification in benign and malignant ovarian tumors
    Amis, S. J.
    Coulter-Smith, S. D.
    Crow, J. C.
    Maclean, A. B.
    Perrett, C. W.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2005, 15 (01) : 58 - 65
  • [48] Significance of u-PA and PAI-1 expression on diseased glomeruli
    Hong, Yin-Feng
    Zhang, Zhi-Gang
    Zhang, Xiu-Rong
    Guo, Mu-Yi
    [J]. Fudan University Journal of Medical Sciences, 2001, 28 (01): : 17 - 20
  • [49] Plasma values for u-PA in children
    P. Zeitler
    V. Schuster
    [J]. European Journal of Pediatrics, 1999, 158 : S205 - S208
  • [50] Plasma values for u-PA in children
    Zeitler, P
    Schuster, V
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 1999, 158 (Suppl 3) : S205 - S208